FIELD: chemistry.
SUBSTANCE: invention relates to derivatives 
.
EFFECT: technical result: novel compounds have been obtained - phenothiazine derivatives, which can be used to treat microbial infections such as tuberculosis.
7 cl, 1 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHENYL FORMAMIDINE DERIVATIVES, HAVING ANTIMYCOBACTERIAL ACTIVITY | 2018 |
|
RU2702224C2 |
| COMBINED THERAPY OF TUBERCULOSIS | 2009 |
|
RU2484819C2 |
| FURILIDENE FURANONE DERIVATIVES OF USNIC ACID AS NEW ANTITUBERCULOSIS AGENTS | 2013 |
|
RU2533707C1 |
| 5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
| DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
| DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
| D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
| COMPOUND, A PHARMACEUTICAL COMPOSITION, A MEDICINAL AGENT, USE OF THE COMPOUND, A PHARMACEUTICAL COMPOSITION, A MEDICINAL AGENT | 2015 |
|
RU2723545C2 |
| CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
| NOVEL BENZOTHIAZINONE DERIVATIVES AND USE THEREOF AS ANTIBACTERIAL AGENTS | 2006 |
|
RU2395508C1 |
